Can Buspirone Cause Vertigo?
Yes, buspirone can cause dizziness and vertigo, though true vertigo (as opposed to lightheadedness) is rare. According to FDA labeling data, dizziness is one of the most common adverse effects of buspirone, occurring in 12% of patients in controlled trials compared to 3% with placebo 1. However, postmarketing surveillance specifically identifies vertigo as a rare adverse event that has been voluntarily reported since the drug's introduction 1.
Understanding the Distinction
The FDA distinguishes between two related symptoms:
- Dizziness and lightheadedness: Very common (12% and 3% respectively in clinical trials) and among the most frequently reported adverse effects 1
- True vertigo: Rare, reported in postmarketing experience but occurring in less than 1/1,000 patients 1
Dizziness was significant enough to cause treatment discontinuation in 3.4% of patients during premarketing trials, making it one of the primary reasons patients stopped buspirone 1.
Clinical Context and Mechanism
The dizziness/vertigo associated with buspirone differs from vestibular causes of vertigo. The guidelines on vertigo management 2 discuss vestibular suppressants like benzodiazepines and antihistamines but do not include buspirone in this category, as it works through 5-HT1A receptor agonism rather than vestibular suppression 3.
Comparative Risk Profile
Recent meta-analysis data 3 confirms that buspirone causes significantly more dizziness than placebo (OR = 4.66,95% CI: 2.07-10.47). Historical comparative data shows buspirone's dizziness rate (9%) is substantially lower than benzodiazepines like lorazepam (58%) or alprazolam (43%) 4.
Clinical Management Considerations
If a patient on buspirone reports vertigo, consider:
- Timing: 76% of movement-related adverse effects from buspirone occur within one month of initiation 5
- Dose relationship: Mean doses associated with adverse CNS effects were around 42 mg/day 5, though dizziness occurs across the therapeutic range (10-30 mg/day) 1
- Resolution: When buspirone-related symptoms occur, 87.5% resolve within one month of discontinuation 5
Important Caveat
Do not assume all vertigo in a patient taking buspirone is drug-related. True vestibular vertigo, posterior circulation stroke, and other serious causes must still be excluded based on clinical presentation, particularly if the patient has acute vestibular syndrome or focal neurological findings 6.
The most practical approach: If vertigo develops shortly after starting buspirone (especially within the first month) and no other concerning features are present, consider dose reduction or discontinuation as symptoms typically resolve quickly upon stopping the medication.